Arcellx
Michelle Gilson is the current Chief Financial Officer at Arcellx, Inc. Prior to this, Michelle held various positions in reputable companies such as Canaccord Genuity Group Inc., Jefferies, Nomura, Oppenheimer & Co. Inc., Goldman Sachs, and Wedbush Securities. Michelle's primary focus has been in biotech equity research, utilizing their expertise in the field. Michelle earned their Bachelor of Science in Business Administration with a concentration in Finance from the University of Southern California's Marshall School of Business.
This person is not in any offices
Arcellx
2 followers
Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.